COLCORONA Trial

COLCHICINE CORONAVIRUS SARS-COV2 TRIAL (COLCORONA)

If you are diagnosed with and/or test POSITIVE for COVID-19 you may be eligible to participate in an important new trial designed to prevent hospitalization and death, using the FDA-approved drug COLCHICINE.

Criteria:

• At least 40 years of age or older
• Have one of the following high-risk conditions – age 70 or older, obesity, uncontrolled high blood pressure (systolic blood pressure over 150), asthma, chronic lung disease, diabetes, heart failure, coronary artery disease, fever over 101.1 degrees within the last 48 hours.
• Results from prior kidney function test (GFR) will be needed from your physician. Please obtain these results by calling your Physician as soon as possible.
• There are few exclusions other than pregnancy.

Help us advance our understanding of COVID-19 and potentially save thousands if not millions of patients from hospitalization and death. If you are diagnosed with COVID-19 infection, please contact us immediately for further information regarding your participation in COLCORONA.

This project is funded by NIH-NHLBI R01 Supplement, Canadian Ministry of Health, and the Bill and Melinda Gates Foundation. The drug is provided by PharmaScience.

Steps To Take:

1. CONTACT THE REGIONAL TRIAL COORDINATOR WITHIN 24 HOURS OF DIAGNOSIS (661)716-4751
2. YOU WILL BE CONTACTED BY THE COLCORONA TEAM AND GIVEN INFORMATION ON THE TRIAL AS WELL AS ASKED A SERIES OF QUESTIONS TO DETERMINE IF YOU QUALIFY FOR THE STUDY
3. IF YOU QUALIFY YOU WILL BE ENTERED INTO THE TRIAL AND BEGIN MEDICATION WITHIN 48 HOURS OF YOUR POSITIVE TEST RESULTS OR DIAGNOSIS OF COVID 19.
4. STUDY DRUG WILL BE DELIVERED TO YOU WITHIN 4 HOURS USING A CONTACTLESS APPROACH

Make a difference Kern County!

To participate call 66.716-4751.